Myomo (MYO) FCF Margin Growth (3y) (2019 - 2025)
Myomo (MYO) FCF Margin Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 60.00 |
| 10 | Myomo | 67.26 Mn | 48.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4,212.00 |
| Jun 30, 2025 | -3,143.00 |
| Mar 31, 2025 | 2,729.00 |
| Dec 31, 2024 | 6,671.00 |
| Sep 30, 2024 | 3,194.00 |
| Jun 30, 2024 | 8,890.00 |
| Mar 31, 2024 | 429.00 |
| Dec 31, 2023 | -1,989.00 |
| Sep 30, 2023 | 5,920.00 |
| Jun 30, 2023 | 42,191.00 |
| Mar 31, 2023 | 18,929.00 |
| Dec 31, 2022 | 11,372.00 |
| Sep 30, 2022 | 30,743.00 |
| Jun 30, 2022 | 18,976.00 |
| Mar 31, 2022 | 31,517.00 |
| Dec 31, 2021 | 23,761.00 |
| Sep 30, 2021 | 36,196.00 |
| Jun 30, 2021 | 25,747.00 |
| Mar 31, 2021 | 65,175.00 |
| Dec 31, 2020 | 26,233.00 |